Randomized Clinical Trial to Evaluate the Morphological Changes in the Adventitial Vasa Vasorum Density and Biological Markers of Endothelial Dysfunction in Subjects with Moderate Obesity Undergoing a Very Low-Calorie Ketogenic Diet.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
23 Dec 2021
Historique:
received: 26 11 2021
revised: 18 12 2021
accepted: 20 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

Weight loss after bariatric surgery decreases the earlier expansion of the adventitial vasa vasorum (VV), a biomarker of early atheromatous disease. However, no data are available regarding weight loss achieved by very low calorie ketogenic diets (VLCKD) on VV and lipid-based atherogenic indices. A randomized clinical trial was performed to examine changes in adventitial VV density in 20 patients with moderate obesity who underwent a 6-month very low calorie ketogenic diet (VLCKD, 600-800 kcal/day), and 10 participants with hypocaloric diet based on the Mediterranean Diet (MedDiet, estimated reduction of 500 kcal on the usual intake). Contrast-enhanced carotid ultrasound was used to assess the VV. Body composition analysis was also used. The atherogenic index of plasma (log (triglycerides to high-density lipoprotein cholesterol ratio)) and the triglyceride-glucose index were calculated. Serum concentrations of soluble intercellular adhesion molecule 1 (sICAM-1), and soluble vascular cell adhesion molecule 1 (sVCAM-1) were measured. The impact of weight on quality of life-lite (IWQOL-Lite) questionnaire was administered. Participants of intervention groups displayed a similar VV values. Significant improvements of BMI (-5.3 [-6.9 to -3.6] kg/m

Identifiants

pubmed: 35010908
pii: nu14010033
doi: 10.3390/nu14010033
pmc: PMC8746664
pii:
doi:

Substances chimiques

Biomarkers 0
Cholesterol, HDL 0
Vascular Cell Adhesion Molecule-1 0
Intercellular Adhesion Molecule-1 126547-89-5

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : PronoKal Group (Spain)

Références

Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):579-87
pubmed: 27133458
Nutrients. 2018 Sep 21;10(10):
pubmed: 30241426
Int J Mol Sci. 2015 May 20;16(5):11574-608
pubmed: 26006236
Am J Physiol. 1981 May;240(5):H781-7
pubmed: 7235037
Arch Med Res. 2019 Jul;50(5):285-294
pubmed: 31593853
Nutrients. 2020 Sep 09;12(9):
pubmed: 32916989
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Eur Rev Med Pharmacol Sci. 2016 Jul;20(12):2613-21
pubmed: 27383313
Biomedicines. 2020 Aug 25;8(9):
pubmed: 32854210
Obes Res. 2004 Nov;12 Suppl 2:115S-23S
pubmed: 15601959
Circulation. 2002 Aug 13;106(7):820-5
pubmed: 12176954
Biomed Res Int. 2014;2014:701571
pubmed: 24724094
Surg Obes Relat Dis. 2020 Oct;16(10):1419-1428
pubmed: 32694041
Cardiovasc Diabetol. 2018 May 1;17(1):56
pubmed: 29712560
Rev Endocr Metab Disord. 2020 Sep;21(3):381-397
pubmed: 32803691
Front Immunol. 2018 Apr 17;9:706
pubmed: 29719532
JAMA. 2014 Feb 26;311(8):806-14
pubmed: 24570244
Circulation. 2005 Aug 16;112(7):976-83
pubmed: 16087797
Angiology. 2017 Jul;68(6):472-493
pubmed: 27568384
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2569-2576
pubmed: 32878476
Endocrine. 2016 Oct;54(1):111-122
pubmed: 27117144
Rev Endocr Metab Disord. 2020 Mar;21(1):1-3
pubmed: 32080796
J Thorac Dis. 2018 Nov;10(11):6137-6146
pubmed: 30622785
Am J Physiol Cell Physiol. 2017 Nov 1;313(5):C567-C574
pubmed: 28814403
Clin Nutr. 2010 Apr;29(2):154-9
pubmed: 20060626
Can J Cardiol. 2015 Feb;31(2):184-94
pubmed: 25661553
Qual Life Res. 2002 Mar;11(2):157-71
pubmed: 12018739
Front Nutr. 2021 Jul 16;8:702802
pubmed: 34336911
Lancet Public Health. 2018 Oct;3(10):e490-e497
pubmed: 30177479
Age Ageing. 2019 Jul 1;48(4):601
pubmed: 31081853
Clin Cases Miner Bone Metab. 2014 Sep;11(3):177-80
pubmed: 25568649
Circulation. 2004 Oct 5;110(14):2032-8
pubmed: 15451780
Cardiovasc Ultrasound. 2015 Apr 17;13:20
pubmed: 25889409
Drug Discov Today. 2016 Oct;21(10):1578-1595
pubmed: 27265770
Front Endocrinol (Lausanne). 2020 Sep 14;11:607
pubmed: 33042004
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1723-30
pubmed: 24947528
J Clin Endocrinol Metab. 2017 Feb 1;102(2):488-498
pubmed: 27754807
Physiol Genomics. 2013 Aug 15;45(16):697-709
pubmed: 23737535
Obes Surg. 2018 Dec;28(12):3935-3942
pubmed: 30030728
PLoS One. 2019 Feb 5;14(2):e0211742
pubmed: 30721271
Nutrients. 2019 Jun 17;11(6):
pubmed: 31212934
J Endocrinol Invest. 2019 Nov;42(11):1365-1386
pubmed: 31111407
Curr Obes Rep. 2018 Dec;7(4):276-288
pubmed: 30155850
Minerva Endocrinol (Torino). 2021 Jun;46(2):161-167
pubmed: 33213120
Rev Endocr Metab Disord. 2020 Mar;21(1):5-16
pubmed: 31705259
Eur Cardiol. 2021 May 17;16:e20
pubmed: 34093741
Obes Facts. 2021;14(2):222-245
pubmed: 33882506
Lipids. 2008 Jan;43(1):65-77
pubmed: 18046594

Auteurs

Enric Sánchez (E)

Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, 25198 Lleida, Spain.

Maria-Dolores Santos (MD)

Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, 25198 Lleida, Spain.
Endocrinology and Nutrition Department, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.

Maitane Nuñez-Garcia (M)

Pronokal Group, 08009 Barcelona, Spain.

Marta Bueno (M)

Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, 25198 Lleida, Spain.
Endocrinology and Nutrition Department, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.

Ignacio Sajoux (I)

Pronokal Group, 08009 Barcelona, Spain.

Andree Yeramian (A)

Endocrinology and Nutrition Department, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.

Albert Lecube (A)

Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, 25198 Lleida, Spain.
Endocrinology and Nutrition Department, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH